Dr. Robert J. Laningham, MD
Family Medicine (Family Medicine Physician)
4015 Interstate 45 N Ste 220
Conroe, TX 77304
Who else practices at this address →
Montgomery County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Texas Medical School at Houston (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,575
Licensed in Texas since 1997, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: University of Texas Medical School at Houston
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
TX license K3601 (first issued 1997; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Hermann Hospital System Houston, TX
- Houston Methodist the Woodlands Hospital The Woodlands, TX
- St Luke's the Woodlands Hospital The Woodlands, TX
- HCA Houston Healthcare Conroe Conroe, TX
- Aspire Hospital Conroe, TX
Medical groups
- Conroe Willis Family Medicine PLLC (6 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,575
- Services billed
- 107,340
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, testosterone cypionate, 1 mg | 61,501 | 38 |
| Established patient office or other outpatient visit, 30-39 minutes | 2,354 | 1,000 |
| Injection, dexamethasone sodium phosphate, 1 mg | 2,131 | 186 |
| Insertion of needle into vein for collection of blood sample | 1,330 | 776 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,158 | 742 |
| Blood test, comprehensive group of blood chemicals | 1,104 | 720 |
| Blood test, thyroid stimulating hormone (tsh) | 983 | 690 |
| Thyroid hormone, t3 measurement, free | 972 | 678 |
| Thyroxine (thyroid chemical), free | 958 | 675 |
| Hemoglobin a1c level | 922 | 646 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Conroe, TX | 554 |
| Atorvastatin Calcium Other prescribers in Conroe, TX | 525 |
| Gabapentin Other prescribers in Conroe, TX | 414 |
| Amlodipine Besylate Other prescribers in Conroe, TX | 379 |
| Losartan Potassium Other prescribers in Conroe, TX | 355 |
| Lisinopril Other prescribers in Conroe, TX | 337 |
| Rosuvastatin Calcium Other prescribers in Conroe, TX | 270 |
| Tamsulosin Hcl Other prescribers in Conroe, TX | 239 |
| Buprenorphine-Naloxone (buprenorphine hcl/naloxone hcl) Other prescribers in Conroe, TX | 234 |
| Omeprazole Other prescribers in Conroe, TX | 233 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 43 payments worth $739 in total to this clinician.
| Dexcom, Inc. | $291 |
|---|---|
| Amgen Inc. | $149 |
| Abbott Laboratories | $82.83 |
| Astellas Pharma US Inc | $82.76 |
| Inspire Medical Systems, Inc. | $77.19 |
| Indivior Inc. | $30.28 |
| AbbVie Inc. | $14.81 |
| Echosens North America, Inc. | $10.85 |
| Food and Beverage | $739 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $32,638 in research payments for these studies, mostly to the institutions running them.
- A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)
Eli Lilly and Company · Active, not recruiting · NCT05026866
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.